Keywords: DCCT، کنترل دیابت و عوارض جانبی; ADA, American Diabetic Association; CHD, coronary heart disease; CVD, cardiovascular disease; DCCT, Diabetes Control and Complications Trial; DECODE, collaborative analysis of diagnostic criteria in Europe study group; DPP, Diabetes Prevention Program; DM
مقالات ISI DCCT، کنترل دیابت و عوارض جانبی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DCCT، کنترل دیابت و عوارض جانبی; T1D, type 1 diabetes; T2D, type 2 diabetes; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; HbA1c, glycated hemoglobin; ITR, insulin therapeutic regimen; DSMP, Diabetes Self-Management Profil
Keywords: DCCT، کنترل دیابت و عوارض جانبی; ADA, American Diabetes Association; Apo, apolipoprotein; DCCT, Diabetes Control and Complications Trial; EASD, European Association for the Study of Diabetes; EDIC, Epidemiology of Diabetes Interventions and Complications trial; eGDR, estimated glucose di
Keywords: DCCT، کنترل دیابت و عوارض جانبی; urinary tract infections; diabetes mellitus; risk factorsAER, albumin excretion rate; BMI, body mass index; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; HbA1c, glycated hemoglobin; MNSI, M
Keywords: DCCT، کنترل دیابت و عوارض جانبی; Diabetes; Elderly; Quality indicators; Guidelines; Nursing homeATC, Anatomical Therapeutic Classification System; BMI, Body mass index; DBP, Diastolic blood pressure, mmHg.; DM, Diabetes Mellitus; DCCT, Diabetes Control and Complications Trial; e-GFR, Est
Frameshift mutations in the insulin gene leading to prolonged molecule of insulin in two families with Maturity-Onset Diabetes of the Young
Keywords: DCCT، کنترل دیابت و عوارض جانبی; Diabetes; MODY; insulin gene; mutationBMI, body mass index; DCCT, Diabetes Control and Complications Trial; ER, endoplasmatic reticulum; GAD, glutamic acid decarboxylase; GCK, glucokinase; HNF1A, hepatocyte nuclear factor 1-alpha; HNF4A, hepatocyte nuclea
Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients
Keywords: DCCT، کنترل دیابت و عوارض جانبی; ACE, angiotensin converting enzyme; ALR, aldose reductase; BMI, body mass index; DR, diabetic retinopathy; DCCT, Diabetes Control and Complications Trial; HLA, human leucocyte antigen; NOS, nitric oxide synthase; PCR, polymerase chain reaction; RAGE, rece
Euglycemic progression: Worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities
Keywords: DCCT، کنترل دیابت و عوارض جانبی; HbA1C, hemoglobin A1c; DCCT, diabetes control and complications trial; CVD, cardiovascular disease; UKPDS, United Kingdom Prospective Diabetes Study; ACCORD, Action to Control Cardiovascular Risk in DiabetesDiabetic retinopathy; Intensified glycemic contr
The long and winding road to optimal HbA1c measurement
Keywords: DCCT، کنترل دیابت و عوارض جانبی; HbA1c, hemoglobin A1c; DCCT, Diabetes Control and Complications Trial; UKPDS, United Kingdom Prospective Diabetes Study; NGSP, National Glycohemoglobin Standardization Program; IFCC, International Federation of Clinical Chemistry; GHB, glycated hemoglobin
Type 1 diabetes in Cheshire: Cardiometabolic risk factor trends (2004–2009)
Keywords: DCCT، کنترل دیابت و عوارض جانبی; BMI, body mass index; BP, blood pressure; DCCT, Diabetes Control and Complications Trial; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; EMIS, Egton Medical Information Systems; GP, general practitioner; GMS, general medical services;
Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats
Keywords: DCCT، کنترل دیابت و عوارض جانبی; AGE, advanced glycated end products; AR, aldose reductase; BUN, blood urea nitrogen; BSA, bovine serum albumin; CAT, catalase; DCCT, diabetes control and complications trial; DPPH, 1,1-diphenyl-2-picrylhydrazyl; ECM, extracellular matrix; Glib, glibenclam
Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes
Keywords: DCCT، کنترل دیابت و عوارض جانبی; ADDQoL, Audit of Diabetes-Dependent Quality of Life; ANOVA, analysis of variance; BMI, body mass index; DAFNE, Dose Adjustment For Normal Eating; DCCT, Diabetes Control and Complications Trial; DTSQ, Diabetes Treatment Satisfaction Questionnaire; HbA1c, h
Clinical Research in Diabetes and Urinary Incontinence: What We Know and Need to Know
Keywords: DCCT، کنترل دیابت و عوارض جانبی; urinary incontinence; obesity; diabetes mellitus, type 1; diabetes mellitus, type 2; prediabetic stateAHEAD, Action for Health in Diabetes; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications
Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes
Keywords: DCCT، کنترل دیابت و عوارض جانبی; VEGF, Vascular endothelial growth factor; I/D, insertion/deletion; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; PCR, polymerase chain reaction; ETDRS, Early Treatment Diabetic Retinopathy
Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study
Keywords: DCCT، کنترل دیابت و عوارض جانبی; AUC, Area under the concentration curve; Cmax, Peak plasma concentration; CI, Confidence interval; CV, Coefficient of variation; CL/F, Apparent clearance; DCCT, Diabetes Control and Complications Trial; GLP-1, Glucagon-like peptide-1; LS, Least squares; S
Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort
Keywords: DCCT، کنترل دیابت و عوارض جانبی; urinary tract infections; diabetes mellitus; type 1; prevalence; risk factorsAER, albumin excretion rate; aOR, adjusted odds ratio; ASB, asymptomatic bacteriuria; DCCT, Diabetes Control and Complications Trial; DM, diabetes mellitus; EDIC, Epidemiology of
Temporal Trends in the Treatment of Pediatric Type 1 Diabetes and Impact on Acute Outcomes
Keywords: DCCT، کنترل دیابت و عوارض جانبی; A1c, Hemoglobin A1c; CSII, Continuous subcutaneous insulin infusion; DCCT, Diabetes Control and Complications Trial; ER, Emergency room; IR, Incidence rate; MDI, Multiple daily injections; RA, Research assistant; SMBG, Self-monitoring of blood glucose; T1
Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital
Keywords: DCCT، کنترل دیابت و عوارض جانبی; CI, confidence interval; DCCT, diabetes control and complications trial; HbA1c, hemoglobin A1c; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; JDS, Japan Diabetes Society; OGTT, oral glucose tolerance test
Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis
Keywords: DCCT، کنترل دیابت و عوارض جانبی; CF, cystic fibrosis; CFRD, cystic fibrosis related diabetes; MPG, mean plasma glucose concentration; DCCT, diabetes control and complications trial; HbA1c, glycosylated haemoglobin; CGMS, continuous glucose monitoring systemCystic fibrosis; HbA1c; Cystic
Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment
Keywords: DCCT، کنترل دیابت و عوارض جانبی; BMI, Body mass index; DCCT, Diabetes Control and Complications Trial; HbA1c, Glycosylated hemoglobin; SES, Socioeconomic status; T1DM, Type 1 diabetes mellitus
Hyperglycemic brain injury in the rat
Keywords: DCCT، کنترل دیابت و عوارض جانبی; DCCT, Diabetes Control and Complications Trial; STZ, streptozotocin; STZ-D, streptozotocin-induced diabetes; HbA1c, hemoglobin A1C; GLC, gas–liquid chromatography; HPLC, high-pressure liquid chromatography; NSE, neuron-specific enolase; PBS, phosphate-buf
Development of an ELISA for esRAGE and its application to type 1 diabetic patients
Keywords: DCCT، کنترل دیابت و عوارض جانبی; AGE, advanced glycation endproducts; CV, coefficient of variation; DCCT, Diabetes Control and Complications Trial; esRAGE, endogenous secretory RAGE; HMGB-1, high mobility group box-1; RAGE, receptor for AGE; UAE, urinary albumin excretionAGE; RAGE; esRAG